BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, July 5, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 1997

View Archived Issues

SmithKline Beecham and Nycomed disclose hemoregulatory compounds

Read More

Pharmacia & Upjohn discloses agents for diabetes

Read More

Antimalarial agents from Roche

Read More

Selective dopamine autoreceptor agonists prepared by American Home Products

Read More

HIV protease inhibitors described by Searle

Read More

Synaptic and Merck & Co. prepare selective human alpha1A-adrenoceptor antagonists

Read More

MMP/TNF-alpha inhibitors from Abbott

Read More

Inhibitors of tyrosine kinase disclosed by Pharmacia & Upjohn

Read More

Garlic has beneficial effects in model of volume overload heart failure

Read More

Lifecore Biomedical to distribute LifeCell's AlloDerm in U.S.

Read More

Sublingual captopril and nifedipine compared in patients with hypertensive crises

Read More

RPR licenses Dilacor XR to Watson

Read More

Proteoglycan synthesis increased by rhBMP-2

Read More

Update on Alliance/Hoechst Marion Roussel agreement for LiquiVent

Read More

Suppressive effect of KE-298 on MMP production

Read More

Phase I results reported for Cortecs' oral insulin

Read More

Japanese companies focus on overseas development

Read More

Company profile: The Medicines Company

Read More

Prostacyclin derivative in development for skin ulcers

Read More

Summary of perospirone clinical trials

Read More

Hemodialyzer efficacy established in patients

Read More

Double identity of Bcl-2 protein described

Read More

Preliminary results reported for Cortecs' Flustat

Read More

Phase III trials show significant positive effect for sertindole on negative symptoms

Read More

Oxford Molecular Group enters drug design agreement with Dainippon

Read More

Faulding forms Faulding Soltec DDS

Read More

Novopharm granted final approval by U.S. Federal Court to market generic Zantac

Read More

Duloxetine not different from placebo in double-blind depression study

Read More

Preliminary efficacy and safety studies with panamesine in schizophrenia

Read More

Vysis' TriGen approved in France

Read More

Effects of befloxatone on psychomotor performance and memory in the elderly

Read More

VX-740: new lead antiinflammatory compound from Vertex/HMR

Read More

New agents for tachycardia from CV Therapeutics

Read More

New cardiovascular agent in development at CV Therapeutics

Read More

Agent for restenosis in preclinical development at CV Therapeutics

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing